Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuno Gil

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Expert Review of Clinical Pharmacology|June 13, 2015
Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancerMariacarmela Santarpia, Nuno Gil, Rafael Rosell
Journal of Neuroimmunology|August 10, 2020
Nivolumab-induced seronegative encephalitisGonçalo Cabral, Filipa Ladeira, Nuno Gil
Molecules (Basel, Switzerland)|December 21, 2010
Antioxidant activity of lignin phenolic compounds extracted from kraft and sulphite black liquorsHélio Faustino, Nuno Gil, Cecília Baptista, et al.
Radiology Case Reports|June 1, 2018
Pulmonary side effects of nivolumab in a patient treated for gynecological malignancyJoana Ip, Sara Beliao, Rogerio Valente-Matos, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|June 9, 2014
C1-C2 pigmented villonodular synovitis and clear cell carcinoma: unexpected presentation of a rare disease and a review of the literatureJosé Pedro Lavrador, Edson Oliveira, Nuno Gil, et al.
Frontiers in Oncology|November 3, 2022
Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinomaFilipa Ferreira da Silva, Rita Barata, Inês Rolim, et al.
Cancers|September 28, 2024
Novel DNA Repair Inhibitors Targeting XPG to Enhance Cisplatin Therapy in Non-Small Cell Lung Cancer: Insights from In Silico and Cell-Based StudiesRita Manguinhas, Patrícia A Serra, Nuno Gil, et al.
Cancers|June 27, 2024
AI Applied to Volatile Organic Compound (VOC) Profiles from Exhaled Breath Air for Early Detection of Lung CancerManuel Vinhas, Pedro M Leitão, Bernardo S Raimundo, et al.
Virchows Archiv : an International Journal of Pathology|November 22, 2024
Clinical and histopathological features of immune checkpoint inhibitor-induced lung toxicityInes Rolim, Antonio Lopez-Beltran, Joana Ip, et al.
International Journal of Molecular Sciences|January 27, 2024
Unveiling Novel ERCC1-XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental DesignRita Manguinhas, Patrícia A Serra, Rita B Soares, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|June 13, 2015
Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancerMariacarmela Santarpia, Nuno Gil, Rafael Rosell
Journal of Neuroimmunology|August 10, 2020
Nivolumab-induced seronegative encephalitisGonçalo Cabral, Filipa Ladeira, Nuno Gil
Molecules (Basel, Switzerland)|December 21, 2010
Antioxidant activity of lignin phenolic compounds extracted from kraft and sulphite black liquorsHélio Faustino, Nuno Gil, Cecília Baptista, et al.
Radiology Case Reports|June 1, 2018
Pulmonary side effects of nivolumab in a patient treated for gynecological malignancyJoana Ip, Sara Beliao, Rogerio Valente-Matos, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|June 9, 2014
C1-C2 pigmented villonodular synovitis and clear cell carcinoma: unexpected presentation of a rare disease and a review of the literatureJosé Pedro Lavrador, Edson Oliveira, Nuno Gil, et al.
Frontiers in Oncology|November 3, 2022
Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinomaFilipa Ferreira da Silva, Rita Barata, Inês Rolim, et al.
Cancers|September 28, 2024
Novel DNA Repair Inhibitors Targeting XPG to Enhance Cisplatin Therapy in Non-Small Cell Lung Cancer: Insights from In Silico and Cell-Based StudiesRita Manguinhas, Patrícia A Serra, Nuno Gil, et al.
Cancers|June 27, 2024
AI Applied to Volatile Organic Compound (VOC) Profiles from Exhaled Breath Air for Early Detection of Lung CancerManuel Vinhas, Pedro M Leitão, Bernardo S Raimundo, et al.
Virchows Archiv : an International Journal of Pathology|November 22, 2024
Clinical and histopathological features of immune checkpoint inhibitor-induced lung toxicityInes Rolim, Antonio Lopez-Beltran, Joana Ip, et al.
International Journal of Molecular Sciences|January 27, 2024
Unveiling Novel ERCC1-XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental DesignRita Manguinhas, Patrícia A Serra, Rita B Soares, et al.
Pageof 2